Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03180164
Other study ID # CLD
Secondary ID
Status Not yet recruiting
Phase N/A
First received June 6, 2017
Last updated January 8, 2018
Start date October 2018
Est. completion date October 2019

Study information

Verified date January 2018
Source Assiut University
Contact Maha Ahmed El-Kholy
Phone 00201096956205
Email maha_elkholy@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic airways diseases involve alterations in the person's social roles, relationships and self-perception so demands continual psychological adjustment .

Also Kunik studied patients with chronic breathing disorders for depression and anxiety and found that 65% of patients were positive for depression and anxiety.

Shackell found that patients' anxiety and fears of breathlessness and dying extended into the night and were aggravated by feelings of isolation and frustration. One patient reported that they often thought 'am I going to see the next morning?'


Description:

This fear and sense of helplessness can lead to panic and evidence suggests that patients with chronic breathlessness often call for emergency assistance during the night According to GOLD report 2017, anxiety and depression in chronic obstructive pulmonary disease patients are both associated with poor prognosis.

Much of the evidence explored so far relates to chronic obstructive pulmonary disease. While other chronic lung diseases have received less attention In addition to, several studies have been found relationship between asthma and psychological disturbance .One review of literature describes an increased prevalence of psychological co-morbidity in asthmatic adults and another research suggests that anxiety and depression are more common in patients with moderate to severe asthma than in the general population Gift. found significantly greater self-reported depression scores among patients with chronic obstructive pulmonary disease receiving prednisone compared to patients not receiving any steroids.

Interestingly, the psychiatric sequel of steroid treatment are often sudden in onset and appear to generally occur within 2 weeks after steroid introduction


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1
Est. completion date October 2019
Est. primary completion date October 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Chronic airways diseases as chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis

Exclusion Criteria:

- Diabetes Mellitus and Hypertension.

- Cardiac diseases.

- Chronic renal and liver diseases.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
hospital anxiety and depression scale
self-assessment scale has been developed and found to be a reliable instrument for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary compare anxiety and depression in different forms of chronic lung diseases by hospital anxiety and depression scale 10 minutes
See also
  Status Clinical Trial Phase
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Completed NCT00783978 - Surfactant Disorders and Chronic Lung Disease N/A
Not yet recruiting NCT05025774 - Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
Completed NCT04663685 - MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults. N/A
Recruiting NCT06112730 - Nutritional Supplementation in Patients With Chronic Respiratory Disease N/A
Completed NCT02544984 - The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease N/A
Recruiting NCT01721655 - Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease Phase 2/Phase 3
Completed NCT00233064 - Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) Phase 4
Recruiting NCT05866302 - Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Not yet recruiting NCT06326957 - Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE) N/A
Completed NCT01326611 - Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants Phase 4
Completed NCT05776264 - Exercise Strategies to Motivate and Relieve Stress N/A
Completed NCT03773991 - Dyspnea Assessment in Hemodialysis Patients
Completed NCT02055339 - Pilot Study Comparing Different Modes of Non-invasive Ventilation for the Oral Feeding of Preterm Infants N/A
Withdrawn NCT03673566 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO N/A
Completed NCT02426112 - Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children Phase 3
Recruiting NCT00710112 - Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
Withdrawn NCT03673579 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB N/A
Active, not recruiting NCT03018717 - Integral Clinical Plan Shared With or Without Telemonitoring of Constants in Patient With Chronic Diseases N/A
Completed NCT03385330 - BPD Saturation TARgeting N/A